Probiotic study for bacterial vaginosis in women
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests if a probiotic called LRa05 can help treat bacterial vaginosis (an imbalance in vaginal bacteria) and support ovary health. It may be an option for premenopausal women with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old and still have periods (premenopausal).
- You are sexually active.
- You have been diagnosed with bacterial vaginosis (BV) with a Nugent score of 7 or higher.
- You do not have other types of vaginal infections (like yeast or certain STIs).
- You are not pregnant, planning pregnancy, or breastfeeding.
- You have not used antibiotics in the last 5 days and are not on long-term birth control or immune-suppressing medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This study tests whether introducing beneficial organisms into the vagina can help treat bacterial vaginosis (a common vaginal imbalance). You'll be part of the FRESH research program and receive either the treatment or a comparison option.
This study tests whether a specific probiotic—Lactobacillus crispatus—can help prevent bacterial vaginosis from coming back. If you have had BV multiple times and recently finished antibiotics, you may be able to join.
This trial is testing a probiotic (friendly bacteria) treatment for postmenopausal women who have bacterial vaginosis. It aims to see if the probiotic can improve vaginal health.
This study tests a new drug called LCFA-01 to make sure it's safe and works as expected in healthy women. The drug is being developed to treat bacterial vaginosis, a common vaginal infection.
Hear when a new Patients With Bacterial Vaginosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.